The snake venom toxin convulxin activates platelets through the collagen receptor glycoprotein VI (GPVI)/Fc receptor ␥-chain (FcR ␥-chain) complex leading to tyrosine phosphorylation and activation of the tyrosine Syk and phospholipase C␥2 (PLC␥2). In the present study, we demonstrate that convulxin is a considerably more powerful agonist than collagen or the GPVI-selective collagen-related peptide (CRP). Confirmation that the response to convulxin is mediated solely via Syk was provided by studies on Syk-deficient platelets. The increase in phosphorylation of the FcR ␥-chain is associated with marked increases in tyrosine phosphorylation of downstream proteins including Syk, linker for activation of T cells (LAT), SLP-76, and PLC␥2. The transmembrane adapter LAT coprecipitates with SLP-76 and PLC␥2, as well as with a number of other adapter proteins, some of which have not been previously described in platelets, including Cbl, Grb2, Gads, and SKAP-HOM. Gads is constitutively associated with SLP-76 and is probably the protein bridging its association with LAT. There was no detectable association between Grb2 and SLP-76 in control or stimulated cells, suggesting that the interaction of LAT with Grb2 is present in a separate complex to that of LAT-Gads-SLP-76. These results show that the trimeric convulxin stimulates a much greater phosphorylation of the FcR ␥-chain and subsequent downstream responses relative to CRP and collagen, presumably because of its ability to cause a greater degree of cross-linking of GPVI. The adapter LAT appears to play a critical role in recruiting a number of other adapter proteins to the surface membrane in response to activation of GPVI, presumably at sites of glycolipidenriched microdomains, enabling an organized signaling cascade that leads to platelet activation.
The snake venom toxin convulxin activates platelets through the collagen receptor glycoprotein VI (GPVI)/Fc receptor ␥-chain (FcR ␥-chain) complex leading to tyrosine phosphorylation and activation of the tyrosine Syk and phospholipase C␥2 (PLC␥2). In the present study, we demonstrate that convulxin is a considerably more powerful agonist than collagen or the GPVI-selective collagen-related peptide (CRP). Confirmation that the response to convulxin is mediated solely via Syk was provided by studies on Syk-deficient platelets. The increase in phosphorylation of the FcR ␥-chain is associated with marked increases in tyrosine phosphorylation of downstream proteins including Syk, linker for activation of T cells (LAT), SLP-76, and PLC␥2. The transmembrane adapter LAT coprecipitates with SLP-76 and PLC␥2, as well as with a number of other adapter proteins, some of which have not been previously described in platelets, including Cbl, Grb2, Gads, and SKAP-HOM. Gads is constitutively associated with SLP-76 and is probably the protein bridging its association with LAT. There was no detectable association between Grb2 and SLP-76 in control or stimulated cells, suggesting that the interaction of LAT with Grb2 is present in a separate complex to that of LAT-Gads-SLP-76. These results show that the trimeric convulxin stimulates a much greater phosphorylation of the FcR ␥-chain and subsequent downstream responses relative to CRP and collagen, presumably because of its ability to cause a greater degree of cross-linking of GPVI. The adapter LAT appears to play a critical role in recruiting a number of other adapter proteins to the surface membrane in response to activation of GPVI, presumably at sites of glycolipidenriched microdomains, enabling an organized signaling cascade that leads to platelet activation.
Platelets express a remarkably large number of receptors for collagen, including the integrin ␣ 2 ␤ 1 and the immunoglobulin receptor glycoprotein VI (GPVI) 1 (1) . It is generally accepted that ␣ 2 ␤ 1 is the major receptor supporting adhesion of platelets to collagen, while GPVI mediates activation. Evidence for this includes the observation that the GPVI-selective agonists collagen-related peptide (CRP) and convulxin are powerful platelet agonists, yet do not bind ␣ 2 ␤ 1 . GPVI is associated with the Fc receptor (FcR) ␥-chain in the membrane (2, 3) . Cross-linking of GPVI induces tyrosine phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) in the cytoplasmic tail of FcR ␥-chain leading to a tyrosine phosphorylation-regulated cascade that involves Syk and PLC␥2 (4) . The sequence of events that underlie phosphorylation of PLC␥2 and subsequent platelet activation, however, are not established. The adapter proteins LAT (linker for activation of T cells) and SLP-76 undergo tyrosine phosphorylation downstream of Syk and have critical, but undefined roles in the regulation of PLC␥2 (5) (6) (7) .
LAT is a 36 -38 kDa integral membrane adapter protein that was first identified in T cells (8) . Activation of ZAP-70 through the T cell receptor is believed to phosphorylate LAT resulting in subsequent recruitment of Grb2, PLC␥1, and other signaling molecules to the plasma membrane. LAT contains nine tyrosine residues in its cytoplasmic domain that are conserved between the murine and human sequences, five of which are surrounded by the optimal binding sequence for binding to the Src homology 2 (SH2) domain of Grb2 (9) . The majority of LAT, a fraction of PLC␥1, and several other signaling molecules are present in glycolipid-enriched microdomains (GEMs) in activated T cells. It is proposed that LAT is central to T cell activation, serving as a novel linker molecule targeting key proteins to membrane microdomains for regulated signaling.
SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa) is a cytoplasmic adapter protein that was initially identified as a tyrosine-phosphorylated protein from stimulated T cells that associates with the SH3 domain of the Grb2 adapter in vitro (10) . SLP-76 has a carboxyl-terminal SH2 domain that binds to tyrosine-phosphorylated proteins, a central prolinerich region that associates with Grb2 and three N-terminal tyrosine residues, which lie within the optimal binding sequence of the GTP exchange factor, Vav (11) . SLP-76 is believed to be a substrate for ZAP-70 in stimulated T cells, with phosphorylation taking place on two of the three tyrosines that fall within the optimal sequence for association with Vav (12) . SLP-76 has been shown to associate with Vav in stimulated T cells through this region and also with the adapter SLAP-130 (SLP-76-associated phosphoprotein of 130 kDa), which binds to its SH2 domain (12, 13) . SLP-76 is essential for activation of PLC␥1 and mitogen-activated protein kinase in stimulated T cells (14) .
LAT and SLP-76 play central roles in signaling by GPVI in platelets. Tyrosine phosphorylation of PLC␥2 is substantially reduced in LAT-deficient and SLP-76-deficient platelets, and there is a corresponding inhibition of platelet activation (5-7). Both adapters are thought to play critical roles in recruiting PLC␥2 to the membrane. LAT also associates with the p85␣ subunit of phosphatidylinositol 3-kinase (PI 3-kinase) in platelets stimulated by GPVI, suggesting that it lies upstream of the PI 3-kinase pathway (15) . An association between SLP-76 and the adapter SLAP-130 in platelets has been also reported (5) .
Recently, several new adapter proteins have been cloned and shown to become incorporated into intracellular complexes following T cell receptor activation. SKAP-HOM (SKAP55 homologue), a homologue of SKAP55 (Src kinase-associated phosphoprotein of 55 kDa), was identified as a T cell adapter that binds specifically with the Fyn SH2 domain in vitro (16) . SKAP-HOM has one pleckstrin homology and one SH3 domain. SKAP-HOM also associates with SLAP130 in activated T cells, although a complex of SKAP-HOM, SLAP-130, and SLP-76 has not been reported (16, 17) . A second adapter protein, Gads (Grb2-related adapter downstream of Shc), (also known as Grpl (Grb2-related protein of the lymphoid system) and Grf40 (Grb2 family member of 40 kDa)) is a Grb2-related protein originally identified on the basis of its interaction with the tyrosinephosphorylated form of the adapter Shc (18 -20) . It has one SH2 domain and two SH3 domains. Recent studies revealed that Gads is expressed strictly in hematopoietic cells and that SLP-76 and LAT interact with Gads through their SH3 and SH2 domains, respectively, following cross-linking of the T cell receptor (18) .
We have investigated the effects of the GPVI-selective snake venom toxin, convulxin, on tyrosine phosphorylation in platelets. Convulxin is a C-type lectin, made of two subunits, ␣ and ␤, linked by disulfide bridges forming an ␣ 3 ␤ 3 complex (21) . We show that convulxin is a considerably more powerful agonist at GPVI than collagen or CRP, inducing a much greater degree of tyrosine phosphorylation and protein-protein interactions. We also present data to support a critical role of LAT in GPVImediated signaling in platelets by demonstrating that it associates with several proteins including Gads and SKAP-HOM during platelet activation via convulxin. LAT appears to be a central adapter protein linking the GPVI-FcR ␥-chain-Syk pathway to the regulation of a number of downstream pathways.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents-CRP (GCP*(GPP) 10 GCP*G, using singleletter amino acid code, where P* represents hydroxyproline) was crosslinked via cysteine residues as described previously (22) ; CRP was kindly donated by Drs. M. Barnes, G. Knight, and R. Farndale (Department of Biochemistry, University of Cambridge, UK). Convulxin was purified from the venom of Crotalus durissus terrificus according to published procedures (21) . Purified convulxin gave similar results to the crude venom. Horm-Chemie collagen (collagen fibers from equine tendon) was purchased from Nycomed (Munich, Germany). Anti-phosphotyrosine mAb 4G10, anti-LAT polyclonal antibody, anti-FcR ␥-chain mAb, and polyclonal anti-SLAP130 rabbit serum were purchased from Upstate Biotechnology, Inc. (TCS Biological Ltd., Botolph Claydon, UK). SLP-76 polyclonal antibody was kindly donated by Dr. Gary Koretzky (University of Pennsylvania, Philadelphia, PA). Anti-Gads polyclonal antibody and anti-SKAP-HOM mAb were previously described (16, 18) . Anti-Grb2 polyclonal antibody and anti-Cbl mAb were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). The Syk-deficient radiation chimeric mice were described previously (23) . Other reagents were from previously described sources (5, 7) .
Preparation and Stimulation of Platelets-Human blood was taken from drug-free volunteers on the day of an experiment using acidic citrate dextrose (120 mmol/liter sodium citrate, 110 mmol/liter glucose, 80 mmol/liter citric acid). Platelet-rich plasma was obtained by centrifugation at 200 ϫ g for 20 min, and platelets were isolated by centrifugation at 1000 ϫ g for 10 min in the presence of prostacyclin (0.1 g/ml). Platelets were resuspended in a modified Tyrode's-Hepes buffer (134 mM NaCl, 0.34 mM Na 2 HPO 4 , 2.9 mM KCl, 12 mM NaHCO 3 , 20 mM Hepes, 5 mM glucose, and 1 mM MgCl 2 , pH 7.3) in the presence of prostacyclin (0.1 g/ml), recentrifuged at 1000 ϫ g for 10 min, and resuspended in the above buffer containing 1 mM EGTA and 10 M indomethacin to a density of 5 ϫ 10 8 cells/ml. Mouse platelets were prepared as described previously (24) . Platelets were resuspended in the above buffer containing 1 mM EGTA and 10 M indomethacin for 30 min prior to experiments. Stimulation of platelets was carried out at 37°C in an aggregometer with continuous stirring at 1,200 rpm for the time indicated.
5-HT Secretion Studies-Platelets were labeled in platelet-rich plasma with 0.5 Ci of [ Platelets were stimulated by convulxin, CRP, or collagen and then quenched by addition of an equal volume of 6% glutaraldehyde in phosphate buffer. Samples were microcentrifuged at 15,000 ϫ g for 2 min and the supernatant analyzed by liquid scintillation counter. Results were expressed as means Ϯ S.E.
Immunoprecipitation and Re-immunoprecipitation-Stimulations were terminated by the addition of an equal volume of ice-cold lysis buffer (2% (v/v) Nonidet P-40, 20 mM Tris, 300 mM NaCl, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 2 mM Na 3 VO 4 , 10 g/ml leupeptin, 10 g/ml aprotinin, and 1 g/ml pepstatin A, pH 7.3). Detergent-insoluble debris was removed by centrifugation at 15,000 ϫ g for 5 min, and the supernatant precleared with protein A-Sepharose (50% (w/v) in Tris-buffered saline plus Tween 20 (TBS-T: 20 mM Tris, 137 mM NaCl, 0.1% (v/v) Tween 20, pH 7.6)) for 1 h at 4°C. Antibodies were added and each sample rotated at 4°C for 120 min. The Sepharose pellet was washed sequentially in lysis buffer and TBS-T, before the addition of Laemmli sample buffer. In re-immunoprecipitation experiments, immunoprecipitated complexes were dissociated by boiling for 10 min in the lysis buffer described above, containing 2% SDS. Dissociated proteins were renatured by addition of lysis buffer with 1% Nonidet P-40 to lower the concentration of SDS to 0.1%, and then re-immunoprecipitated with the indicated antibodies bound to protein A-Sepharose at 4°C. The Sepharose beads were washed and Laemmli sample buffer added. The specificity of the interactions was verified with control, isotype-matched antibodies.
Immunoblotting-Proteins were separated by SDS-PAGE on 10% or 8 -18% gels and electrically transferred onto polyvinylidene difluoride (PVDF) membranes that were then blocked by incubation in 10% (w/v) bovine serum albumin dissolved in TBS-T. Primary and secondary antibodies were diluted in TBS-T containing 2% (w/v) bovine serum albumin and incubated with PVDF membranes for 60 min at room temperature. Blots were washed in TBS-T after each incubation with antibodies and then developed using an enhanced chemiluminescence system (ECL, Amersham Pharmacia Biotech, Cardiff, UK).
Fusion Protein Precipitation Studies-A GST fusion protein containing the tandem SH2 domains of Syk (GST-Syk-SH2) was constructed and expressed as described previously (25) , and bound to glutathioneagarose. Precipitation of platelet proteins with the fusion construct was performed as described previously (25) . Precipitated proteins were separated by SDS-PAGE using 8 -18% gels under either reducing or nonreducing conditions and transferred onto PVDF membranes.
RESULTS

Convulxin Is a More Powerful Platelet Agonist than CRP-
The collagen receptor can be selectively activated by the synthetic collagen, CRP (21, 26) , and by convulxin, a component of the venom of the rattlesnake C. durissus terrificus (27, 28) .
Using maximal concentrations, convulxin was found to induce a more rapid and greater degree of tyrosine phosphorylation in platelets in comparison to CRP (Fig. 1A) . Additionally, it was notable that tyrosine phosphorylation of number of proteins, including those of 12-14 and 38 kDa, peaked within 15 s, whereas their phosphorylation in response to CRP was delayed. Immunoprecipitation studies using a specific antiserum identified the 12-14-kDa protein as the FcR ␥-chain. Determination of concentration response curves to CRP and convulxin confirmed that the toxin induced a much greater degree of phosphorylation of the FcR ␥-chain (Fig. 1B) . For example, convulxin stimulated a 3.2 Ϯ 0.4-fold (n ϭ 3) increase in tyrosine phosphorylation of FcR ␥-chain relative to that seen in response to CRP at 30 s (an even greater difference would be present at 15 s, the time of peak response to convulxin as shown in Fig. 1A) . A similar result was obtained following precipitation of the FcR ␥-chain using the tandem SH2 domains of Syk (2.8 Ϯ 0.3-fold, n ϭ 3) (Fig. 1C) (29) . This set of observations demonstrate that the trimeric convulxin is a more powerful agonist than CRP, possibly because of its ability to cross-link multiple GPVI receptors leading to a greater degree of tyrosine phosphorylation of the FcR ␥-chain. Evidence that convulxin signals solely through the GPVI-FcR ␥-chain pathway leading to tyrosine phosphorylation of Syk was provided by studies on Syk-deficient murine platelets. Tyrosine phosphorylation of PLC␥2 induced by convulxin was completely inhibited in Syk-deficient mouse platelets (Fig. 1D) .
The functional consequence of the increase in tyrosine phosphorylation of the FcR ␥-chain was determined by measurement of [ 3 H]5-HT release from dense granules. The maximal response to convulxin was approximately 2.5-fold greater than that to CRP, and considerably greater than that to collagen (Fig. 2) .
LAT Associates with SLP-76, Lyn, PLC␥2, and Cbl in Convulxin-stimulated Platelets-A candidate for the transiently tyrosine-phosphorylated 38-kDa protein is the adapter LAT, which has been shown to be tyrosine-phosphorylated in platelets following stimulation by collagen, CRP, and Fc␥RIIA crosslinking (7) . Immunoprecipitation of LAT demonstrated that it is also heavily tyrosine-phosphorylated in convulxin-stimulated platelets (Fig. 3A) . Phosphorylation by convulxin peaks at 15 s and declines thereafter. Major tyrosine-phosphorylated bands of 52-55 and 75 kDa, and a minor band of 130 kDa, were observed in LAT immunoprecipitates in convulxin-stimulated samples. The same bands were also seen in collagen-and CRP-stimulated platelets, albeit to a lesser degree (7). The 52-55-and 76-kDa bands were identified as Lyn, which exists as a doublet in platelets, and SLP-76 by reimmunoprecipitation and probing for phosphotyrosine (Fig. 3, B and C) . The 130-kDa band migrates close to Cbl and PLC␥2, both of which are also tyrosine-phosphorylated in response to convulxin in platelets (28) . The presence of either of these proteins, however, was not established by Western blotting, possibly because of a low level of expression. To determine whether PLC␥2 and/or Cbl associate with LAT, a re-immunoprecipitation strategy was used as described under "Experimental Procedures." Re-immunoprecipitates were blotted for phosphotyrosine using anti-phosphotyrosine mAb 4G10 to identify the position of reprecipitated proteins. Fig. 3 (D and E) shows that PLC␥2 and Cbl coprecipitate with LAT, demonstrating that both are component of the 130-kDa tyrosine-phosphorylated band. The converse experiment in which LAT was immunoprecipitated and the sample re-immunoprecipitated with anti-PLC␥2 or anti-Cbl gave the same result. We were unable to demonstrate an association between PLC␥2 and Cbl in convulxin-activated platelets following immunoprecipitation of either protein, suggesting that they are not associated with each other or in a trimeric complex with LAT.
Immunoprecipitation of SLP-76 from platelets lysates following stimulation by convulxin revealed that it undergoes marked tyrosine phosphorylation and associates with tyrosinephosphorylated proteins of 38, 52-55, and 130 kDa (Fig. 4A) . The time of peak tyrosine phosphorylation of SLP-76 by convulxin, like that of LAT, was 15 s. Re-immunoprecipitation studies identified the 38-kDa protein as LAT, and the 52-55-and 130-kDa proteins were identified as Lyn and SLAP-130 by reprobing (Fig. 4, B-D) , respectively. We were unable to detect an association between SLP-76 and PLC␥2.
Interaction of Gads and Grb2 with Tyrosine-phosphorylated LAT, SLP-76, and the FcR ␥-Chain Platelets Stimulated by Convulxin-Although we have shown that LAT associates with SLP-76 and PLC␥2 in convulxin-stimulated platelets, we did not observe coprecipitation of PLC␥2 and SLP-76 suggesting that a complex of all three proteins was not precipitated. The observation that tyrosine phosphorylation of SLP-76 is slightly reduced in LAT-deficient platelets suggests that the two adapters are regulated through independent pathways, but that a small amount of SLP-76 is regulated downstream of LAT (7). The adapter protein Grb2 has been previously reported to associate in vitro with LAT and SLP-76 via its SH2 and SH3 domains, respectively, following T cell receptor engagement (10) . We were therefore interested in investigating whether Grb2 interacts with LAT and SLP-76 in convulxin-stimulated platelets. A major tyrosine-phosphorylated band of 38 kDa is observed in Grb2 immunoprecipitates from convulxin-stimulated platelets under reduced and nonreduced conditions (Fig.  5A) , and this was identified as LAT by reimmunoprecipitation and blotting for phosphotyrosine (Fig. 5B) . In contrast, an interaction between SLP-76 and Grb2 could not be detected following stimulation by convulxin.
Tyrosine-phosphorylated bands of 25 and 72 kDa coimmunoprecipitate with Grb2 under nonreducing conditions in convulxin-stimulated platelets. The 72-kDa protein was shown to contain Syk by immunoblotting (Fig. 5C ). The 25-kDa protein migrated at 12-14 kDa under reduced conditions, a characteristic of the disulfide-linked homodimeric FcR ␥-chain. Identification of the 12/25-kDa band as the FcR ␥-chain was confirmed by immunoblotting (Fig. 5D ). An unidentified band of 150 kDa was also observed in Grb2 immunoprecipitates under reducing conditions in stimulated platelets, which was identified as SHIP (SH2 containing inositol 5Ј-phosphatase) by reprobing (Fig. 5E) . A number of unidentified, minor tyrosine bands are also seen in Grb2 immunoprecipitates from convulxin-stimulated cells. These results demonstrate that Grb2 does not provide a link between LAT and SLP-76 in platelets. However, Following immunoprecipitation with anti-LAT polyclonal antibody, proteins were separated by SDS-PAGE and transferred to PVDF membrane. The membranes were immunoblotted for Lyn using an anti-Lyn polyclonal antibody, or for SLP-76 using an anti-SLP-76 polyclonal antibody (B and C). Following immunoprecipitation with anti-PLC␥2 or anti-Cbl mAb, immunoprecipitated complexes were dissociated by boiling for 10 min in lysis buffer, containing 2% SDS. Dissociated proteins were renatured by addition of lysis buffer with 1% Nonidet P-40 to make up to 0.1% SDS, and re-immunoprecipitated with anti-LAT polyclonal antibody bound to protein A-Sepharose. Re-immunoprecipitates were separated, transferred as described above, and immunoblotted for phosphotyrosine using anti-phosphotyrosine mAb 4G10 (D and E).
FIG. 4. SLP-76 associates with LAT, Lyn, and SLAP-130 in con-
vulxin-stimulated platelets. SLP-76 was immunoprecipitated from lysates as described above. The membrane was immunoblotted for phosphotyrosine using anti-phosphotyrosine mAb 4G10 (A, upper panel). Then the membrane was stripped and reprobed for SLP-76 with anti-SLP-76 polyclonal antibody (A, lower panel). Following immunoprecipitation with anti-SLP-76 polyclonal antibody, reimmunoprecipitation was done as described in the legend of Fig. 3 , and LAT was detected using anti-phosphotyrosine mAb 4G10 (B). Following immunoprecipitation with anti-SLP-76 polyclonal antibody, proteins were separated by SDS-PAGE and transferred to PVDF membrane. The membranes were immunoblotted for Lyn using an anti-Lyn polyclonal antibody, or for SLAP-130 using an anti-SLAP-130 polyclonal antibody (C and D).
Grb2 is likely to link LAT, FcR ␥-chain, and Syk to a number of other proteins via its SH3 domain such as SOS, a GTP exchange factor for Ras.
Recently, an adapter protein that is closely related to Grb2 was identified independently by three groups and named Gads (18), Grpl (19) , and Grf40 (20) . Gads forms a complex with LAT and SLP-76 in activated T cells. The association of Gads with LAT and SLP-76 in convulxin-stimulated platelets was investigated. Gads associates with a number of tyrosine-phosphorylated proteins in platelets following stimulation by convulxin, with major bands observed at 38 and 76 kDa under reduced and nonreduced conditions (Fig. 6A ). These two bands were shown to contain LAT and SLP-76 by reimmunoprecipitation and Western blotting, respectively (Fig. 6, B and C) . Additionally, the FcR ␥-chain was shown to coimmunoprecipitate with Gads upon stimulation of GPVI accounting for the tyrosinephosphorylated band of 25 kDa under nonreduced conditions (Fig. 6, A and D) . Two other unidentified tyrosine-phosphorylated bands of 55 and 62 kDa were also seen under reduced conditions in the Gads immunoprecipitate from stimulated platelets. Gads itself was not tyrosine-phosphorylated by convulxin. These findings suggest the possibility that LAT associates with SLP-76 through the adapter Gads in convulxin-stimulated platelets rather than by direct association.
SKAP-HOM Associates with LAT, SLAP130, the FcR ␥-Chain, and Grb2 in Convulxin-stimulated Platelets-In the present study, several adapter proteins that were originally identified in T cells have been shown to be incorporated into intracellular signaling complexes in platelets following activation of GPVI, including LAT, SLP-76, SLAP130, Cbl, Grb2, and Gads. Recently, Fyn, which also forms part of the GPVI signaling cascade (32) (33) (34) , was reported to form a complex with the novel adapters SKAP-55 and SKAP-HOM in T cells (16, 35, 36) . Western blotting studies revealed that platelets express SKAP-HOM as doublet of 50 -55 kDa, but have a negligible amount of SKAP-55. The possible role of SKAP-HOM in the GPVI receptor signaling pathway was addressed through immunoprecipitation and blotting for phosphotyrosine. SKAP-HOM is constitutively tyrosine-phosphorylated in resting human platelets, and its level of phosphorylation does not increase following stimulation by convulxin (Fig. 7A) . SKAP-HOM coprecipitates with tyrosine-phosphorylated bands of 38, 75, and 130 kDa in platelets stimulated by convulxin under reducing and nonreducing conditions (Fig. 7A) . The 130-kDa tyrosine-phosphorylated protein was constitutively associated with SKAP-HOM and underwent only a small increase in phosphorylation upon activation of GPVI. SLAP130 was identified as a major component of this band by Western blotting (Fig. 7B) . Re-immunoprecipitation analyses identified LAT as a component of the 38-kDa band (Fig. 7C) . The identity of the 75-kDa protein is not known, although immunoblotting and reimmunoprecipitation studies were unable to reveal the presence of SLP-76. A tyrosine-phosphorylated protein that ran at 25 kDa under nonreducing conditions and at 12-14 kDa under reducing conditions was identified as FcR ␥-chain (Fig. 7D) . We also found that SKAP-HOM was constitutively associated with Grb2 in resting and convulxin-stimulated platelets (Fig. 7E) .
DISCUSSION
The recent cloning of GPVI has revealed it to be a novel member of the immunoglobulin family of surface receptors, sharing close homology to the Fc␣ receptor (1). This is consistent with mechanism of intracellular signaling by GPVI, namely that it signals through the same pathway as that used by immune receptors (37) . The protein components that underlie the activation of PLC␥2 and PI 3-kinase by GPVI appear to be a hybrid of those used by the T cell receptor, B cell receptor, and Fc receptors. For example, GPVI signaling is mediated via the FcR ␥-chain, which is used by Fc receptors, the tyrosine kinase Syk, a component of Fc receptor and B cell receptor pathways, the adapters LAT and SLP-76, which form part of the T cell receptor signaling cascade, and PLC␥2, which is predominantly utilized by the B cell receptor pathway. Nevertheless, despite the unique nature of the GPVI signaling pathway, the overall characteristics are the same as those for other immune receptors.
The present study has characterized the GPVI signaling pathway in platelets in further detail through the use of the snake venom toxin convulxin, focusing on the role that adapter proteins play in the signaling cascade. The trimeric convulxin has been shown to be a much more powerful agonist than collagen or the synthetic GPVI-selective collagen-related peptide, CRP, probably because of its ability to induce a much greater degree of cross-linking of GPVI and a higher stoichiometry of tyrosine phosphorylation of the FcR ␥-chain. This results in a more powerful activation of functional responses as demonstrated by release of 5-HT from dense granules.
Convulxin stimulates tyrosine phosphorylation and/or assembly into intracellular signaling complexes of a number of adapter proteins, which have been previously shown to participate in T cell receptor signaling, namely LAT, SLP-76, Cbl, and SLAP-130. Adapters that do not undergo phosphorylation in response to GPVI but are recruited into intracellular signaling complexes are Grb2, Gads, and SKAP-HOM (which is constitutively phosphorylated on tyrosine). The observation that these proteins also participate in T cell receptor signaling emphasizes the close similarity with the signaling cascade used by GPVI. Nevertheless, there are a number of differences. For example, T cells express SKAP55, which is present in negligible levels in platelets, and SKAP-HOM is inducibly rather than constitutively phosphorylated on tyrosine following activation of the T cell receptor. The function of SKAP-HOM in platelets may therefore be similar to that of SKAP55 in T cell activation, which is constitutively tyrosine-phosphorylated (17) . Additionally, we have been unable to find the 55-kDa adapter Shb in platelets, which has been recently reported to interact with LAT and PLC␥1 in T cells (38) .
The much greater degree of stimulation induced by convulxin relative to collagen and CRP facilitates the identification and study of protein-protein interactions that take place with low stoichiometry. For example, a number of interactions have been observed following stimulation by convulxin, which are not readily seen in platelets stimulated by the former two agonists. This includes the interaction of LAT with PLC␥2, Cbl, and SLP-76 (compare the present results with the studies in Refs. 5, 7, and 39). The possibility that these interactions are unique to convulxin, however, rather than being the consequence of its more powerful signaling action seems remote. Interactions between LAT and PLC␥1, Cbl, and SLP-76 have also been reported following activation of the T cell receptor (8, 40) . The interaction of LAT with PLC␥2 is likely to play an important role in bringing the phospholipase to the membrane. This provides a molecular basis for the marked reduction in tyrosine phosphorylation of PLC␥2 and inhibition of platelet activation in LAT-deficient platelets in response to activation of GPVI (7) . The interaction of LAT with Cbl will bring the latter to the membrane, although the significance of this is unclear. The interaction between LAT and SLP-76 is discussed below.
We have reported in the present study that platelets express the Grb2-related adapter, Gads, and compared the interactions of both adapters in stimulated platelets. Both proteins are recruited into intracellular signaling complexes following stimulation by convulxin, and both show strong associations with LAT and the FcR ␥-chain. The association between LAT and Grb2 is consistent with the presence of five conserved tyrosine residues within its sequence, which fall within the optimal binding sequence for the SH2 domain of Grb2. Thus, it seems likely that LAT recruits Grb2 and Gads to the membrane through a direct interaction. The interaction of Grb2 and Gads with the FcR ␥-chain would also lead to their recruitment to the membrane. The FcR ␥-chain lacks the optimal binding sequence for the Grb2 SH2 domain and does not possess a proline-rich region for interaction with its SH3 domain. The interaction with Grb2 may therefore be indirect, possibly mediated through Syk, as this has been identified in Grb2 immunoprecipitates and is known to associate with the FcR ␥-chain (29) .
Gads, but not Grb2, was found to coprecipitate with SLP-76. This observation is the same as in T cells, where it was concluded that Gads provides a link between LAT and SLP-76 (18, 19) . The SH2 domain of Gads binds to LAT, while its SH3 domain is constitutively associated with the proline-rich region of SLP-76. This provides a mechanism of recruitment of SLP-76 to the membrane and places the regulation of the adapter downstream of LAT. Potentially, therefore, this could explain why tyrosine phosphorylation of PLC␥2 is markedly inhibited in LAT-and SLP-76-deficient platelets. However, we have reported that tyrosine phosphorylation of SLP-76 is only partially inhibited in LAT-deficient platelets, and to a lesser extent than the reduction in tyrosine phosphorylation of PLC␥2. Moreover, we did not observe an association between SLP-76 and PLC␥2 in platelets stimulated by convulxin (present study). It is therefore possible that the complex of LAT, Gads, and SLP-76 does not lie upstream of PLC␥2 but has a separate, as yet undetermined, role in platelet activation by GPVI. Studies on platelets from Gads-deficient mice are required to address this question. It is interesting that there was no association between Grb2 and SLP-76 in platelets, despite the ability of these two proteins to interact in vitro. This suggests that these two proteins either associate in an insoluble intracellular complex in platelets or that their access is restricted either by compartmentalization or through competition with Gads.
We have also shown that platelets express the adapter SKAP-HOM but not the closely related SKAP-55. SKAP-HOM is a recently identified adapter protein of unknown function. SKAP-HOM is constitutively phosphorylated on tyrosine in platelets, but its level of phosphorylation does not increase following activation by convulxin. This is in contrast to T cells, where it is expressed as a nonphosphorylated protein in the absence of an external stimulus but becomes phosphorylated following T cell receptor activation (17) . SKAP-HOM is constitutively associated with the adapter SLAP-130 in platelets, as previously reported in T cells. However, we were unable to detect the presence of SLP-76 in SKAP-HOM precipitates, suggesting that the interactions between SLAP-130 and SLP-76 and between SLAP-130 and SKAP-HOM are mutually exclusive. SKAP-HOM was also shown to associate with LAT and with the FcR ␥-chain upon stimulation by convulxin, and to be constitutively associated with Grb2, but not Gads (data not shown). Among the putative tyrosine phosphorylation sites in SKAP-HOM, one has the optimal binding sequence for the SH2 domain of Grb2 (Tyr 298 ) (16) . It is possible that SKAP-HOM directly associates with the SH2 domain of Grb2 via this site, enabling an indirect interaction with LAT. Little is known about the role of SKAP55 or SKAP-HOM, and studies on mice deficient in SKAP-HOM are required to address its role in platelets.
The present study has shown that several adapter molecules are tyrosine-phosphorylated and/or recruited into intracellular signaling complexes following activation of GPVI by convulxin.
Additionally, the p85 subunit of PI 3-kinase associates with LAT in platelets (15) following stimulation by convulxin. Presumably, several more adapters remain to be identified. It is presently unclear why such a large number of adapters are required for signaling by GPVI, although this underscores the importance of protein-protein interactions in intracellular signaling cascades and the critical role played by adapters in the organization of these cascades.
Many of the adapter proteins described in this study, and also other proteins including PLC␥2, associate with the transmembrane adapter LAT. LAT is palmitoylated at two cysteines in the juxtamembrane region, and this has been found to be essential for its targeting to GEMs (9) . GEMs are specialized regions of the membrane, which are rich in proteins and lipids involved in ITAM-based signaling cascades including the Src family kinases Lyn and Fyn, and the lipid phosphatidylinositol 4,5-bisphosphate, the substrate for PLC␥2 and PI 3-kinase. LAT may therefore play a critical role as a scaffold recruiting many of the signaling proteins in the GPVI cascade to GEMs. It therefore seems likely that many of the interactions of proteins with LAT that have been described in this study may be indirect. It is also possible that some proteins and protein interactions are not preserved following solubilization. Further work is required to investigate this and to establish the role of GEMs in platelet signaling by GPVI.
In conclusion, the present study has demonstrated that the trimeric convulxin is a much more powerful agonist at GPVI than collagen or CRP because of its ability to induce a much greater of tyrosine phosphorylation of the FcR ␥-chain ITAM. This has facilitated the discovery of a number of intracellular protein-protein interactions, which have not been previously observed in platelets stimulated by collagen or CRP, including the association of LAT with PLC␥2 and with SLP-76. The present study has further shown that many of the adapter proteins originally identified in T cells also participate in GPVI signaling in platelets, including the two recently identified adapters Gads and SKAP-HOM. Many of the adapters that are expressed in platelets interact either directly or indirectly with LAT including Grb2, Gads, p85 subunit of PI 3-kinase, SKAP-HOM, SLP-76, and Cbl. The interaction of so many proteins with LAT may be explained by their recruitment into GEMS, making it likely that these form critical sites of signaling downstream of GPVI.
